Tatva Chintan Pharma IPO – Review, Bid, Size, Allotment, Subscription, GMP & RHP
Last Updated Date: Nov 17, 2022Let’s have a detailed review of the company and analytics of the Tatva Chintan Pharma IPO release date, IPO offer price, subscription, Tatva Chintan Pharma Chem Limited IPO allotment, grey market price, and other details like the company’s background, its financial positions, its promoters, and other related things.
| Face Value | Rs 10 |
| Price Band | Rs 1073 to Rs 1083 |
| Listing At | BSE, NSE |
| Min. Order Quantity | 13 Shares |
| Listing Date | Jul 29, 2021 |
| Offer for Sale | Rs 2,750 Million |
| Fresh Issue | Rs 2,250 Million |
| IPO Size | Rs 5,000 Million |
| Tick Size | 1 |
Tatva Chintan Pharma IPO is listed at a [●] premium. Check out the live share price by clicking on the below link.
Tatva Chintan Pharma IPO – Summary
They are a specialty chemicals manufacturing company engaged in the manufacture of a diverse portfolio of structure-directing agents (“SDAs”), phase transfer catalysts (“PTCs”), electrolyte salts for supercapacitor batteries and pharmaceutical and agrochemical intermediates, and other specialty chemicals (“PASC”).
Their Company is the largest and only commercial manufacturer of SDAs for zeolites in India. It also enjoys the second-largest position globally
The Promoter of this company is Mr. AJAYKUMAR MANSUKHLAL PATEL, CHINTAN NITINKUMAR SHAH, AND SHEKHAR RASIKLAL SOMANI. The lead manager to the issue is ICICI Securities Limited and JM Financial Limited and the Registrar to this issue is Link Intime India Private Limited.
Check out Related IPO Links:
| Tatva Chintan Pharma IPO GMP |
| Check Allotment – Tatva Chintan Pharma IPO |
Tatva Chintan Pharma IPO Date
The opening and the closing date of the IPO of Tatva Chintan Pharma Limited are Jul 16, 2021, and Jul 20, 2021, respectively.
Tatva Chintan Pharma IPO Subscription
| Day / Date | QIB | NII | RII | Total Subscription |
| 1st Day – 16 July | 0.50x | 1.14x | 8.24x | 4.51x |
| 2nd Day – 17 July | 0.50x | 1.14x | 8.24x | 4.51x |
| 3rd Day – 18 July | 0.50x | 1.14x | 8.24x | 4.51x |
| 4th Day – 19 July | 1.97x | 12.21x | 23.74x | 15.05x |
| 4th Day – 20 July | 185.23x | 512.22x | 35.35x | 180.36x |
| Shares Offered or Net Issue | 931,966 | 698,975 | 1,630,941 | 3,261,882 |
The shares subscribed by the public will be updated here.
Check Tatva Chintan Chem IPO LIVE Subscription
- Tatva Chintan IPO LIVE Bid details on BSE
- Tatva Chintan IPO LIVE Bid details on NSE
For the Latest Bid details click on the above links.
Tatva Chintan Pharma IPO Allotment Status
Here, you can find the Allotment Status of this IPO.
Allotment of Equity Shares pursuant to the Fresh Issue and transfer of the Offered Shares of the Promoter Selling Shareholders pursuant to the Offer for Sale to the successful Bidders. However, the Allotment Status is not yet disclosed.
Tatva Chintan Pharma Limited IPO Listing Date
Find the dates below on basis of allotment, refund, listing, and more:
| Basis of Allotment Finalization | Jul 26, 2021 |
| Refunds Initiation | Jul 27, 2021 |
| Credit of Shares to Demat Account | Jul 28, 2021 |
| Share Listing Date | Jul 29, 2021 |
Tatva Chintan Pharma IPO Price Band
The face value of each share is Rs.10, but the price band of the IPO is Rs.1073 to Rs.1083
Tatva Chintan Pharma IPO Equity Size
This Initial Public Issue of X Equity Shares of Rs.10 each for cash at a price of Rs.1073 to Rs.1083 per equity share aggregating to Rs.5,000 Million.
Tatva Chintan Pharma IPO Share Offering
Fresh Issue: The Issue (excluding the Market Maker Reservation Portion) of [●] Equity Shares of Rs.10/ each, aggregating to Rs.2250 Million
Offer For Sale: X equity Shares of Rs.10/ each, aggregating to Rs.2,750 Million
Issue Size: X Equity Shares of Rs.10 each, aggregating to Rs.5,000 Million
Open Free Demat Account Now!
Tatva Chintan Pharma IPO – Live Performance
The listing date of this IPO is Jul 29, 2021. You can check the live performance of the IPO here, only after it is listed on exchanges.
| Live IPO Performance – Tatva Chintan Share Price |
Tatva Chintan IPO Grey Market Premium
The Tatva Chintan Pharma Limited IPO Grey Market Premium price is Rs 1150, the Kostak rate is Rs 350 and the Subject to Sauda is 10500.
Tatva Chintan Pharma Chem IPO – Company Overview
Their Company is one of the leading global producers of an entire range of PTCs in India and one of the key producers across the globe. As a manufacturer of specialty chemicals, They focus on the application of Their products which form a key ingredient to Their customers’ manufacturing and industrial processes.
For instance, Their SDA and PTC products have various applications in green chemistry, which is pertinent considering the growing focus on green and sustainable technologies.
Apart from Their customers in India, They also export Their products to over 25 countries, including the USA, China, Germany, Japan, South Africa, and the UK.
Tatva Chintan Pharma IPO – Financial Statements
A quick look into the past financial performance of the company to understand its performance of the business and evaluate the growth prospectus:
Financial Summary:
| Amount (in INR & Million) | |||
| 31-Mar-21 | 31-Mar-20 | Mar-19 | |
| Total Assets | 3,148.03 | 2,489.38 | 1,875.08 |
| *Total Revenue | 3,062.92 | 2,646.22 | 2,068.01 |
| Total Expense | 2,455.96 | 2,170.25 | 1,801.57 |
| Profit After Tax | 522.62 | 377.89 | 205.43 |
Earnings per Equity Share (in Million)
| 31-Mar-21 | 31-Mar-20 | Mar-19 | |
| Basic & Diluted | 26.02 | 18.81 | 10.23 |
Tatva Chintan Pharma IPO – Promoters
The Promoter of this company is:
- AJAYKUMAR MANSUKHLAL PATEL,
- CHINTAN NITINKUMAR SHAH, AND
- SHEKHAR RASIKLAL SOMANI
List of Related Parties (Key Managerial Personnel)
- Chintan Nitinkumar Shah, Managing Director
- Ajaykumar Mansukhlal Patel, Whole Time Director
- Shekhar Rasiklal Somani, Whole Time Director
- Manher Chimanlal Desai, Independent Director
- Subhash Ambubhai Patel, Independent Director
Tatva Chintan Pharma IPO – Promoters Holding
- Pre Issue Share Holding – 100%
- Pos Issue Share Holding – 79.17%
Tatva Chintan Pharma IPO Offer Details or Issue Details
| Particulars | No. Of Equity Shares |
| Equity Shares Offered | Up to X Equity Shares aggregating up to Rs.5,000 Million |
| of which: | |
| Issue Reserved for the Market Makers | Up to [●] Equity Shares aggregating up to Rs.[●] Million |
| Net Issue to the Public | Up to [●] Equity Shares aggregating up to Rs.[●] Million |
| Of which: | |
| Retail Investors Portion | Not less than [●] Equity Shares |
| Other than Retail Individual Investors | Not more than [●] Equity Shares |
| Equity Shares outstanding prior to the Issue | 20,087,500 Equity Shares |
| Equity Shares outstanding after the Issue | X Equity Shares |
Tatva Chintan Pharma IPO Issue Object
Their Company proposes to utilize the Net Proceeds towards funding the following objects:
1. Funding capital expenditure requirements for expansion of their Dahej Manufacturing Facility
2. Funding capital expenditure requirements for upgradation at their R&D facility in Vadodara; and
3. General corporate purposes.
Tatva Chintan Chem IPO – Business Strategy
- Expand our existing product portfolio
- Further develop our R&D capabilities
- Increase wallet share with existing customers and continued focus to expand customer base
- Expand our existing manufacturing capacities to capitalise on industry opportunities
Tatva Chintan Pharma IPO – Basis of Offer Price
The issue price is determined by the company in consultation with the Lead manager on the basis of the following qualitative and quantitative factors.
Qualitative factors are:
- Leading manufacturer of structure-directing agents and phase transfer catalysts, with consistent quality;
- Global presence with a wide customer base across various industries having high entry barriers;
- Diversified specialized product portfolio requiring strong technical know-how;
- Modern manufacturing facilities with a focus on ‘green’ chemistry processes;
- Strong R&D capabilities;
- Experienced Promoters with a strong management team; and
- Robust financial performance
The relevant quantitative factors are:
| Basic & Diluted EPS | RONW (%) | NAV (Rs.) | |
| 31-Mar-21 | 26.02 | 31.49 | 82.62 |
| 31-Mar-20 | 18.81 | 32.11 | – |
| Mar-19 | 10.23 | 25.78 | – |
Tatva Chintan Chem IPO: Competitive Peers
| Face Value (Rs.) | P/E | EPS (Rs.) | Return on Net Worth (%) | Total Income (Rs. in Million) | |
| Tatva Chintan Limited | 10 | [●] | 26.02 | 31.49 | 3,062.92 |
| Listed Peers | |||||
| Aarti Industries Limited | 5 | 29.07 | 30.04 | 15.23 | 45,068.00 |
| Navin Fluorine International Limited | 2 | 73.12 | 52.03 | 15.76 | 12,584.37 |
| Alkyl Amines Chemicals Limited | 5 | 25.62 | 144.68 | 37.27 | 12,493.89 |
| Vinati Organics Limited | 1 | 77.41 | 26.20 | 17.45 | 9,801.02 |
| Fine Organics Industries Limited | 5 | 75.01 | 39.25 | 16.45 | 11,503.16 |
Tatva Chintan Pharma IPO Lead Managers
| Lead Managers |
ICICI Securities Limited JM Financial Limited |
Tatva Chintan Pharma IPO Registrar to offer
| Registrar to the Offer |
| Link Intime India Private Limited C-101, 1st Floor, 247 Park Lal Bahadur Shastri Marg, Vikhroli (West) Mumbai, Maharashtra – 400 083 India Telephone: +91 (22) 4918 6200 E-mail: tatva.ipo@linkintime.co.in Website: www.linkintime.co.in Investor grievance e-mail: tatva.ipo@linkintime.co.in Contact person: Shanti Gopalkrishnan SEBI registration number: INR000004058 |
Tatva Chintan Chem IPO – Other Details
- Statutory Auditor – NDJ & Co., Chartered Accountants
- Legal Counsel to the Company – Khaitan & Co
- Bankers to the Company – NA
Tatva Chintan IPO Review by Stock Brokers
| Top Stock Brokers Review | Company Reputation | Competitive Edge | Financial Statement | Popularity Index | Promoters Reputation |
| Angel Broking | 7.5/10 | 7.4/10 | 8.5/10 | 8.1/10 | 7.1/10 |
| Sharekhan | 7.2/10 | 7.1/10 | 8.6/10 | 8.1/10 | 7.2/10 |
| Kotak Securities | 7.3/10 | 7.5/10 | 8.4/10 | 8.1/10 | 7.3/10 |
| ICICI Direct | 7.3/10 | 7.3/10 | 8.7/10 | 8.1/10 | 7.1/10 |
| IIFL | 7.5/10 | 7.2/10 | 8.8/10 | 8.0/10 | 7.1/10 |
| Edelweiss | 7.5/10 | 7.4/10 | 8.4/10 | 8.3/10 | 7.2/10 |
| Zerodha | 7.4/10 | 7.1/10 | 8.5/10 | 8.1/10 | 7.0/10 |
| 5Paisa | 7.1/10 | 7.1/10 | 8.4/10 | 8.1/10 | 7.1/10 |
| Karvy | 7.4/10 | 7.3/10 | 8.2/10 | 8.1/10 | 7.1/10 |
| Motilal Oswal | 7.1/10 | 7.1/10 | 8.6/10 | 8.3/10 | 7.2/10 |
Subscribe to Tatva Chintan Pharma IPO
Tatva Chintan Pharma Limited IPO News
News 1 – Chintan Pharma Limited IPO DRHP Download
News 2 – Tatva Chintan Pharma IPO RHP Download
Tatva Chintan Pharma IPO Review FAQs
What is the Issue Size of Tatva Chintan Pharma IPO?
The Company is making an initial public offer of NA equity shares. They vividly portray the aspects of the issue in this article. You can check the stats on the fresh issue, Offer for sale, and net issue.
What is the Price band of Tatva Chintan IPO?
The price band for this particular IPO, i.e. Tatva Chintan IPO ranges between Rs.1073 to Rs.1083. As far as the face value of the share is of concern, it is Rs.10 per share.
What is the Tatva Chintan IPO Open Date?
The opening and closing dates for Tatva Chintan IPO have been updated. The IPO is set to open on Jul 16, 2021, while the closing date is set at Jul 20, 2021.
What is the Tatva Chintan IPO Allotment Date?
They also have the news regarding the respective allotment dates of Tatva Chintan Pharma Chem IPO. Basis of Allotment finalization is on Jul 26, 2021, refund initiation is on Jul 27, 2021, credit of shares is on Jul 28, 2021, and share listing date is on Jul 29, 2021.
What is the Tatva Chintan Pharma IPO Listing Date?
Shares of Tatva Chintan Chem shall be listed in the exchanges on Jul 29, 2021. The date, when the listing would be done, is stagnant on Jul 29, 2021.
Who is the Registrar of Tatva Chintan Chem IPO?
One of the reputed registrars is managing the issue of Tatva Chintan Pharma Chem IPO, i.e. Link Intime India Private Limited. Their website will help you regarding the further information you are on the lookout for.
Who is the Promoter of Tatva Chintan Chem IPO?
Here are the promoters of Tatva Chintan Chem – AJAYKUMAR MANSUKHLAL PATEL, CHINTAN NITINKUMAR SHAH, AND SHEKHAR RASIKLAL SOMANI. You can refer to the RHP for further information on the promoter. You will find the link to RHP in the article.
What is the GMP of Tatva Chintan Chem IPO?
They have obtained the GMP of Tatva Chintan Chem IPO and it is Rs 1150. Further insights of Kostak rate and subject to sauda or SS are as well included in this report.
Is Tatva Chintan Pharma IPO good for Investment?
They have further provided the financial status of the company in this article, from the past few years. You can refer to the same, and also check the line of operations they are into and then decide to invest in the IPO.
What is the PAT of Tatva Chintan Company?
They have the information of company financials, and according to that, They have the figures from the last few years to provide. PAT for the financial year 2021 in Million is 522.62, 2020 is 377.89, 2019 is 205.43.
Calculate your return on investment!
Asset Class ROI (Rs.) Profit (Rs.) Profit (%) IPO Equity Savings Real Estate Gold Bonds Fixed Deposit Mutual Fund
Market Guide
Featured Topics